CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
Under the Medicare Drug Price Negotiation Program (“Negotiation Program”), CMS directly negotiates the prices of certain high expenditure, single source drugs without generic or biosimilar competition. CMS announced that the […]
Read More
CMS to Lower Drug Costs and Improve Care by Extending Deadline for GENEROUS Model Application
March 2, 2026 Contact: CMS Media Relations (202) 690-6145 | CMS Media Inquiries The Centers for Medicare & Medicaid Services (CMS) is extending the application deadline for prescription drug manufacturers […]
Read More
Feb 26 2026 CMS News Release
FOR IMMEDIATE RELEASE | February 25, 2026 | Contact: CMS Media Relations | (202) 690-6145 | CMS Media Inquiries Trump Administration Prioritizes Affordability by Announcing Major Crackdown on Health Care Fraud Initiative […]
Read More
CMS Proposes 2027 Medicare Advantage and Part D Payment Policies to Improve Payment Accuracy and Sustainability
CMS Newsroom January 26, 2026 The Centers for Medicare & Medicaid Services (CMS) released the Calendar Year (CY) 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates […]
Read More